Tobacco use treatment for HIV patients in Vietnam
Official title: Implementing Tobacco Use Treatment in HIV Clinics in Vietnam
Run by New York University · NCT05162911 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing three different ways to help people with HIV in Vietnam quit smoking and see which method works best for them.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 672 (estimated) |
| Sponsor | New York University Academic / other |
| Locations | 1 site (Hanoi, Nam Tu Liem) |
| Trial ID | NCT05162911 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are current tobacco users who are patients at HIV outpatient clinics in Hanoi and can be reached by phone.
✕Probably not a fit
Patients who are pregnant, nursing, or have serious health conditions such as recent myocardial infarction or arrhythmias may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of three different interventions designed to help tobacco users quit smoking within HIV outpatient clinics in Vietnam. The interventions include a combination of counseling and referral to a national quitline, a structured cessation counseling program, and the addition of nicotine replacement therapy. A total of 672 patients will be randomly assigned to one of the three intervention arms, with their smoking status monitored over a six-month period using biochemical validation. The study also includes formative assessments and pilot testing to ensure the interventions are tailored to the local clinical context.
Why it matters
Potential benefit: If successful, this study could significantly improve smoking cessation rates among people living with HIV, enhancing their overall health and quality of life.
How similar studies have gone: Previous studies have shown success with similar tobacco cessation interventions in various populations, indicating potential for positive outcomes in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients in the HIV OPCs * current tobacco users * patients who live in Hanoi * patients reachable by phone Exclusion Criteria: * patients for whom there is a need for precaution in using NRT will be excluded * patients with recent myocardial infarction (2 weeks) * patients serious underlying arrhythmias * patients who are pregnant or nursing * patients are unable to demonstrate capacity for consent * patients already enrolled in a tobacco use treatment program.
Where it's running
-
Nam Nguyen
Hanoi, Nam Tu Liem, Vietnam Recruiting
Study contacts
- Study coordinator: Donna Shelley, MD MPH
- Email: ds186@nyu.edu
- Phone: 917-494-4210
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One extra structured CBT session to help cancer patients quit smoking
This trial tests whether adding one CBT-based smoking-cessation session to standard brief counseling helps cancer patients quit smoking cigarettes.
-
Relapse-prevention counseling added to standard care for cancer patients who quit smoking at diagnosis
This trial tests whether adding one structured CBT-based relapse-prevention session helps cancer patients who have remained smoke-free since diagnosis stay abstinent longer.
-
Automating Tobacco Cessation in Primary Care
This project tests a workflow in primary care to identify smokers and help them access nicotine replacement therapy (NRT) during routine visits.
-
Text2Quit-Kenya: a mobile message program to help ED patients quit tobacco
Researchers will test a text message-based smoking-cessation program with Kenyan emergency department patients to see if it helps people quit and learn what works in this setting.
-
How people puff IQOS Iluma i vs IQOS 2.4 and how flavors feel
This study tests how exclusive IQOS users puff the newer Iluma i versus the older 2.4, and whether preferred flavor affects puffing and sensory experience.
-
Feasibility of a perinatal smoking and cannabis cessation program
This study tests a perinatal program to help pregnant people quit tobacco and cannabis and stay smoke-free after birth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.